Market News & Trends
CHEMO & Particle Sciences Partner to Provide the Only Development-to-Commercialization Solution
Particle Sciences Inc. and CHEMO recently announced they have formed a partnership to offer complete contract product development and commercial manufacturing of hormone-eluting devices. Particle Sciences…
Cytomedix Acquires Aldagen
Cytomedix, Aldagen, acquisition details, 5 million dollar stock purchase, PRP platform technology, Martin Rosendale, cell selection technology Cytomedix, Inc. recently announced the completion of the…
2/7/2012
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations Foster Delivery Science, a business unit for Foster Corporation, recently announced it has added…
Alize Pharma Licenses ASPAREC Therapy for ALL to EUSA Pharma
Alize Pharma II, recently announced the signing of a licensing agreement with EUSA Pharma for ASPAREC, a new L-asparaginase product currently in Phase I clinical…
Celerion First Early-Stage CRO to Adopt Participant Verification System
Celerion recently announced it has implemented VCT Verify from Verified Clinical Trials, to instantaneously ensure accurate participant identification and qualification for clinical research. Celerion is…
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations
Foster Delivery Science, a business unit for Foster Corporation, recently announced it has added comprehensive in-house laboratory services to expedite the screening of early stage…
Merck KGaA Signs $550 Million Pact With Threshold Pharmaceuticals
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, recently announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to…
Novozymes Wins Innovation Award for Ground-Breaking Half-Life Extension Platform
Novozymes Biopharma, part of Novozymes A/S, recently announced it has received the 2012 Drug Delivery Partnerships (DDP) Technology Innovation award for the company's half-life extension…
OctoPlus Enters Development & Manufacturing Agreement With Ferring Pharmaceuticals
OctoPlus N.V. recently announced a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company. The undisclosed contract…
Zogenix & Battelle to Collaborate on Advanced Drug Delivery Technology
Zogenix, Inc. and Battelle recently announced a unique collaboration with the objective of advancing the development and commercialization of Zogenix's DosePro drug delivery technology outside…
1/31/2012
Amgen to Buy Micromet for $1.16 Billion Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger agreement under which Amgen will…
Amgen to Buy Micromet for $1.16 Billion
Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded…
Catalent Expands Controlled-Release Drug Development & Supply Capabilities
Catalent Pharma Solutions recently announced it is continuing to expand its drug development and delivery capabilities to help customers bring better treatments to patients through…
Encap Drug Delivery Adds New Commercial Product to Portfolio
Encap Drug Delivery, the world's leading contract development and manufacturing organization (CDMO) totally dedicated to liquid and semi-solid (hot melt) filled capsules, recerntly announced the…
New Delivery Platform Discussed at Partnerships Meeting
On January 26, 2012, at the Drug Delivery Partnerships meeting in Las Vegas, a new drug delivery platform was discussed during the session titled Preformulation…
Spectrum Pharmaceuticals to Acquire Worldwide Rights to Market ZEVALIN
Spectrum Pharmaceuticals recently announced it has entered into an agreement to acquire licensing rights to market ZEVALIN (ibritumomab tiuxetan) injection for intravenous use outside the…
1/24/2012
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company, recently announced the acquisition of…
Aptalis Pharma Announces NDA Approval of Oral Powder Formulation of Viread
Aptalis Pharma recently announced the US FDA has approved an NDA for Gilead Sciences, Inc.'s Viread (tenofovir disoproxil fumarate) oral powder in combination with other…
Avila Announces Allowance of IND Application for Oral EGFR Mutant-Selective Inhibitor
Avila Therapeutics, Inc. recently announced it has achieved the first milestone in its Epidermal Growth Factor Receptor (EGFR) Mutant-Selective Inhibitor (EMSI) alliance with Clovis Oncology,…
B. Braun Becomes First to Deliver FDA-Approved 2-g Cefazolin
B. Braun Medical Inc. recently announced it received US FDA approval for 2-g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX…
